Modus Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Modus Advisors's LLY Position: Q2 2026 in Review
Modus Advisors increased its Eli Lilly (LLY) stake by 1.3% in Q2 2026, buying an estimated $57.2K and bringing the position to 4,218 shares worth $5.06M. The position accounts for 1.25% of the portfolio, ranked #29.
Modus Advisors first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Modus Advisors held 4,218 shares of Eli Lilly worth $5.06M as of Q2 2026.
- Modus Advisors bought 56 Eli Lilly shares in Q2 2026, an estimated $57.2K.
- Eli Lilly made up 1.25% of Modus Advisors's portfolio in Q2 2026, its #29 holding.
- Modus Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
- 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Modus Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.